logo
Jiangsu Delfu medical device Co.,Ltd
Email f@cn-huayang.com TEL: 86-181-6882-8053
Home > PRODUCTS > Somatropin Injection >
Prescription Only Somatropin Injection and Recombinant Human Growth Hormone Injection Do Not Freeze and Contraindicated in Acute Critical Illness
  • Prescription Only Somatropin Injection and Recombinant Human Growth Hormone Injection Do Not Freeze and Contraindicated in Acute Critical Illness

Prescription Only Somatropin Injection and Recombinant Human Growth Hormone Injection Do Not Freeze and Contraindicated in Acute Critical Illness

Place of Origin China
Brand Name Delfu
Model Number BZ-VB
Product Details
Activeingredient:
Somatropin
Drugclass:
Recombinant Human Growth Hormone
Dosageform:
Injection
Administrationroute:
Subcutaneous Or Intramuscular
Indications:
Growth Hormone Deficiency, Turner Syndrome, Chronic Kidney Disease, Prader-Willi Syndrome
Storageconditions:
Refrigerate At 2-8°C, Do Not Freeze
Manufacturer:
Various Manufacturers (e.g., Pfizer, Novo Nordisk)
Shelflife:
Typically 24 Months
Highlight: 

Somatropin Injection prescription only

,

Somatropin Injection do not freeze

,

Somatropin Injection acute critical illness contraindication

Product Description

Product Description:

Somatropin Injection is a specialized pharmaceutical product designed to address various growth-related disorders by supplementing the body with synthetic human growth hormone. The active ingredient in this injection is Somatropin, a recombinant form of human growth hormone that closely mimics the natural hormone produced by the pituitary gland. This product is primarily indicated for patients suffering from Growth Hormone Deficiency, Turner Syndrome, Chronic Kidney Disease, and Prader-Willi Syndrome, conditions that often lead to impaired growth and developmental challenges.

The mechanism of action of Somatropin Injection involves stimulating growth and cell reproduction by replicating the effects of natural human growth hormone. When administered, Somatropin binds to specific receptors on the surface of target cells, triggering a cascade of biological responses that promote protein synthesis, increase muscle mass, and enhance bone growth. This makes it an essential treatment for individuals whose bodies do not produce sufficient quantities of human growth hormone, thereby helping to normalize growth patterns and improve overall health outcomes.

One of the key advantages of Somatropin Injection is its ability to effectively restore normal growth rates in children and adolescents with growth hormone deficiencies. In patients with Turner Syndrome, a genetic disorder affecting females, the injection helps stimulate linear growth and improve final adult height. Similarly, for children with Chronic Kidney Disease, Somatropin Injection compensates for growth retardation commonly associated with renal impairment. Additionally, in cases of Prader-Willi Syndrome, it assists in increasing muscle tone, reducing fat mass, and enhancing physical strength, contributing to better quality of life.

The administration of Somatropin Injection is typically done through subcutaneous injection, allowing for convenient and controlled delivery of the hormone. Dosage and treatment duration are carefully determined by healthcare professionals based on the patient's age, weight, and specific medical condition. Regular monitoring is essential to assess treatment efficacy and minimize potential risks. Patients and caregivers are advised to follow prescribed guidelines closely to achieve optimal therapeutic results.

While Somatropin Injection offers significant benefits, it may also cause some common side effects. Patients might experience injection site reactions such as redness, swelling, or discomfort. Other frequently reported side effects include headaches, edema (fluid retention), and muscle pain. These adverse effects are generally mild and transient, but any persistent or severe symptoms should be promptly discussed with a healthcare provider. It is important to note that the use of Somatropin Injection should be under strict medical supervision, especially in individuals with underlying health conditions.

In summary, Somatropin Injection is a critical treatment option for individuals with deficiencies or disorders related to inadequate human growth hormone production. By utilizing the active ingredient Somatropin, this injection effectively stimulates growth and cell reproduction, thereby addressing the root causes of growth impairment in various conditions. Its clinical applications span from Growth Hormone Deficiency and Turner Syndrome to Chronic Kidney Disease and Prader-Willi Syndrome, making it a versatile and valuable therapy. With careful administration and monitoring, Somatropin Injection can significantly improve growth outcomes and enhance the overall well-being of patients requiring human growth hormone supplementation.

 

Applications:

The Somatropin Injection, branded as Delfu and identified by model number BZ-VB, is a recombinant human growth hormone product originating from China. It is manufactured by various reputable manufacturers, including Pfizer and Novo Nordisk. This medicine is designed for administration either subcutaneously or intramuscularly, offering flexibility to healthcare providers and patients. The product is typically delivered using an injection pen, which is compatible with a 3ml cartridge, ensuring precise dosage and ease of use.

This injection pen makes the administration of Somatropin convenient and efficient, especially for patients requiring long-term hormone therapy. The compact design of the pen allows for discreet and portable use, making it suitable for daily treatment routines both at home and in clinical settings. The 3ml cartridge capacity supports multiple doses, reducing the frequency of cartridge replacements and enhancing user compliance.

Somatropin Injection is primarily used in medical scenarios where growth hormone deficiency is diagnosed. It is indicated for children and adults who experience growth failure due to insufficient endogenous growth hormone production. The product is also applied in cases of chronic kidney disease, Turner syndrome, and other conditions requiring recombinant human growth hormone therapy. Due to its potent nature, the injection pen delivery system is crucial for accurate and safe administration in these diverse clinical situations.

Proper storage of Delfu Somatropin Injection is essential to maintain its efficacy. It should be refrigerated at temperatures between 2-8°C and must not be frozen. These storage conditions ensure the stability of the hormone within the 3ml cartridge and prevent degradation that could compromise treatment outcomes.

However, certain contraindications must be observed. The product should not be used in patients with active malignancy, acute critical illness, or those who have hypersensitivity to Somatropin. These precautions are critical to avoid adverse reactions and ensure patient safety during therapy.

In summary, the Delfu Somatropin Injection BZ-VB, delivered via an injection pen equipped with a 3ml cartridge, is suitable for various therapeutic applications involving growth hormone deficiency. Its ease of use, combined with strict storage requirements and clear contraindications, make it an effective and reliable option in clinical and home treatment scenarios.

 

Customization:

Our Somatropin Injection, branded as Delfu with model number BZ-VB, offers comprehensive product customization services to meet your specific needs. Originating from China, this injection is designed to stimulate growth and cell reproduction by mimicking natural growth hormone, ensuring effective treatment outcomes.

We provide Somatropin Injection in a convenient 3ml cartridge format, allowing precise and easy dosage administration. The 3ml cartridge packaging is ideal for both clinical and personal use, ensuring safety and consistency in every dose.

Manufactured by various reputable manufacturers such as Pfizer and Novo Nordisk, our Somatropin Injection guarantees high quality and reliability. The product typically has a shelf life of 24 months, maintaining its efficacy throughout this period.

Customization options include tailoring the 3ml cartridge specifications, labeling, and packaging to suit your distribution and branding requirements. Trust our expertise to deliver premium Somatropin Injection solutions that align perfectly with your business needs.

 

Support and Services:

For technical support and product-related inquiries regarding Somatropin Injection, please refer to the product's package insert for detailed information on usage, dosage, and storage instructions. It is important to follow the guidelines provided by your healthcare professional and the prescribing information to ensure safe and effective treatment.

If you experience any adverse reactions or have questions about the administration of Somatropin Injection, consult your healthcare provider promptly. Proper handling and injection techniques are crucial for optimal results and minimizing potential side effects.

Somatropin Injection should be stored according to the recommended conditions, typically refrigerated at 2°C to 8°C (36°F to 46°F) and protected from light. Do not freeze the product. Always inspect the solution before use; it should be clear and free of particles. Do not use if the solution appears cloudy or contains precipitates.

For additional support, including information on product availability, handling, and disposal, please consult your pharmacist or healthcare professional. They can provide guidance tailored to your treatment needs and answer any specific questions you may have about Somatropin Injection.

 

Packing and Shipping:

Somatropin Injection is packaged in sterile, single-use vials containing the specified dosage of the active ingredient. Each vial is sealed with a tamper-evident cap and labeled with product information including dosage strength, batch number, and expiration date. The vials are individually packed in protective blister packs or cartons to maintain product integrity during handling and transportation.

For shipping, Somatropin Injection must be stored and transported under refrigerated conditions, typically between 2°C and 8°C (36°F and 46°F), to preserve its stability and efficacy. The product is shipped in insulated containers with ice packs or cold chain logistics to ensure consistent temperature control throughout transit. All shipments include temperature monitoring devices and are handled according to pharmaceutical shipping regulations to guarantee the delivery of a safe and effective product.

 

FAQ:

Q1: What is Somatropin Injection Delfu BZ-VB used for?

A1: Somatropin Injection Delfu BZ-VB is used to treat growth hormone deficiency in children and adults, helping to stimulate growth and increase height in children with growth failure.

Q2: Where is the Somatropin Injection Delfu BZ-VB manufactured?

A2: The Somatropin Injection Delfu BZ-VB is manufactured in China.

Q3: How should I store the Somatropin Injection Delfu BZ-VB?

A3: The Somatropin Injection Delfu BZ-VB should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze the product and keep it away from direct light.

Q4: How is Somatropin Injection Delfu BZ-VB administered?

A4: Somatropin Injection Delfu BZ-VB is administered by subcutaneous injection, usually once daily. Your healthcare provider will instruct you on the correct dosage and injection technique.

Q5: Are there any common side effects of Somatropin Injection Delfu BZ-VB?

A5: Some common side effects may include injection site reactions, swelling, joint pain, or muscle pain. If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Contact Us at Any Time

86-181-6882-8053
NO.2890 Luheng Road, Luheng Street,Changzhou Economic Development Zone, Jiangsu Province, China 213025
Send your inquiry directly to us